Document is current
Any future updates will be listed below
-
Authors
Chye, Alexander
Lung, Thomas
Delbaere, Kim
van Schooten, Kimberley S.
Taylor, Morag
Ambrens, Meghan
Howard, Kirsten
Angell, Blake
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1193766)
National Health and Medical Research Council (GNT2010055)
Human Frontier Science Program Fellowship (LT001080/2017)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 29 April 2026
First Online: 21 May 2026
Declarations
Ethics approval and consent to participate: Ethics approval was granted by the ethics committee: University of New South Wales Human Research Ethics Advisory Panel Executive (Project ID: 5113). Informed consent for all study participants was obtained by PureProfile (panel provider), with consent forms approved by the ethics committee. Our study adhered to ethical principles for research involving human participants as per the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: StandingTall is currently distributed in Australia through Neuroscience Research Australia (NeuRA), with future commercialisation planned via Ylva Health Pty Ltd. KD is the Scientific Founder and Chief Executive Officer of Ylva Health Pty Ltd. The other authors declare no other competing interests.
